/-/media/corpsite/assets/park-life/news-and-events/news/logo/hkstp_logo_en_op-dark-mode.svg?mw=1980&rev=578e4e3c3c8a43ae96060191588e8ecc&hash=CDDFB54416A7577AAA399A746252CD83
bONE Ortho Hong Kong Limited730c90a1-4c80-ed11-81ac-6045bd21b175_CompanyLogo_08062026

b-ONE Ortho (Hong Kong) Limited

Company

Description

B-ONE is an orthopaedic company rooted in the Chinese Mainland with a global presence. It is the first and currently the only Chinese domestic orthopaedic company to develop hip and knee joints independently for implantation in the United States. KuanYue's hip and knee joints have been approved by the US FDA and China's NMPA, and are used in top orthopaedic hospitals in both the Chinese Mainland and the US. Adhering to the principle of "American R&D · Made in China · Global Sales", KuanYue has R&D centres and advanced technology innovation laboratories in New Jersey, USA, and Suzhou, China, bringing together outstanding R&D talent from both countries and collaborating with top global doctors to develop innovative technologies and next-generation products. B-ONE provides comprehensive solutions for high-quality hip, knee, shoulder, ankle, wrist, tumour, personalised, customised, and digital surgery needs for both the Chinese and overseas markets.

Product

超交联梯度聚乙烯髋臼内衬(Sapphire GXL)作为国际最新一代的聚乙烯技术,采用国际首创的光化学交联工艺,等效交联度由内向外呈梯度分布。髋臼内衬的内表面为交联度超过250kGy的超级交联层,实现了超低的磨损率;内衬内部实现低度交联,维持机械强度和韧性。同时,Sapphire GXL采用特殊工艺稳定自由基,相较现有含VE高交联内衬进一步提升了氧化稳定性。